OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Interactive ToolsLearning ModulesPresentationsSponsored
Biomarker Consortium
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • 2024 nominations are open for Giants of Cancer Care®
  • In-person and virtual events just for HCPs
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
    • Biomarker Consortium
Advertisement

“HER2 Breast Cancer Talk”: A Review of Data from the SABCS 2020 Virtual Symposium

home / the-talk / her2-breast-cancer-talk-sabcs-2020-virtual-symposium

Advertisement
Current Treatment Landscape for HER2+ Breast Cancer

EP. 1: Current Treatment Landscape for HER2+ Breast Cancer

By Ruth O'Regan, MD, University of Rochester Medical Center
Joyce O'Shaugnessy, MD, Texas Oncology
  • Hope S. Rugo, MD, FASCO, UCSF Helen Diller Family Comprehensive Cancer Center
  • Debu Tripathy, MD, MD Anderson Cancer Center
January 25th 2021
Prognostic Tools for Early-Stage HER2+ Breast Cancer

EP. 2: Prognostic Tools for Early-Stage HER2+ Breast Cancer

By Ruth O'Regan, MD, University of Rochester Medical Center
Joyce O'Shaugnessy, MD, Texas Oncology
  • Hope S. Rugo, MD, FASCO, UCSF Helen Diller Family Comprehensive Cancer Center
  • Debu Tripathy, MD, MD Anderson Cancer Center
January 25th 2021
Updated Data for Metastatic HER2+ Breast Cancer

EP. 3: Updated Data for Metastatic HER2+ Breast Cancer

By Ruth O'Regan, MD, University of Rochester Medical Center
Joyce O'Shaugnessy, MD, Texas Oncology
  • Hope S. Rugo, MD, FASCO, UCSF Helen Diller Family Comprehensive Cancer Center
  • Debu Tripathy, MD, MD Anderson Cancer Center
January 25th 2021

Latest Conference Coverage

Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer

Neoadjuvant Nivolumab Plus Carboplatin/Paclitaxel Elicits High pCR Rates in Early-Stage TNBC

Dr Schmid on the Use of Perioperative Pembrolizumab in TNBC

Dr Khan on Optimizing Local Therapy Using MRI and a 12-Gene Expression Assay in DCIS

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact